v3.26.1
STOCK-BASED COMPENSATION - Schedule of Options Outstanding and Weighted Average Exercise Price (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2026
Dec. 31, 2025
Series A and Series B Warrants      
Options outstanding, beginning balance (in shares)   17,613,352  
Vested and exercisable, ending balance (in shares) 12,584,038 12,584,038 11,042,865
Granted (in shares) 4,985,750    
Exercised (in shares) (144,107)    
Forfeited or expired (in shares) (1,247,568)    
Options outstanding, ending balance (in shares) 21,207,427 21,207,427 17,613,352
Pre-Funded Warrants      
Options outstanding, beginning balance (in dollars per share)   $ 2.68  
Vested and exercisable (in dollars per share) $ 3.03 3.03 $ 3.49
Granted (in dollars per share) 1.74    
Exercised (in dollars per share) 1.37    
Forfeited or expired (in dollars per share) 4.13    
Options outstanding, ending balance (in dollars per share) $ 2.42 $ 2.42 $ 2.68
Weighted Average Remaining Contractual Life in Years and Aggregate Intrinsic Value      
Weighted Average Remaining Contractual Life in Years, Options outstanding 7 years 1 month 17 days   6 years 6 months 21 days
Weighted Average Remaining Contractual Life in Years, Vested and exercisable 5 years 9 months 10 days   5 years 3 months
Aggregate Intrinsic Value, Options outstanding $ 16,908,000 $ 16,908,000 $ 5,332,000
Aggregate Intrinsic Value, Vested and exercisable $ 6,336,000 $ 6,336,000 $ 1,000